ArticlePloS one2023
Guidance for good practice in the application of machine learning in development of toxicological quantitative structure-activity relationships (QSARs).
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Constraint aware and uncertainty informed QSAR modeling of Tetrahymena pyriformis toxicity using physicochemical descriptors.Scientific reports · 2026Article
- Perspective on applicability of data-driven machine learning computational new approach methodologies for hazard identification in chemicals risk assessment.Journal of cheminformatics · 2026Review
- Methodological Challenges in the Application of QSAR Models for Chemical Prioritization and Toxicity Assessment: A Case Study on Aryl Hydrocarbon Receptor Activity in Environmental Pollutant Mixtures.ACS environmental Au · 2026Article
- Current Computational Approaches for the Discovery of Novel Anticancer Agents Targeting VEGFR and SIRT Signaling Pathways.Pharmaceutics · 2026Review
- Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysis.Molecular diversity · 2025Article
- Benchmarking ML in ADMET predictions: the practical impact of feature representations in ligand-based models.Journal of cheminformatics · 2025Article
- Refining Drug-Induced Cholestasis Prediction: An Explainable Consensus Model Integrating Chemical and Biological Fingerprints.Journal of chemical information and modeling · 2025Article
- Reimagining drug regulation in the age of AI: a framework for the AI-enabled Ecosystem for Therapeutics.Frontiers in medicine · 2025Article
- Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy.Archives of toxicology · 2024Article
- Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks.Heliyon · 2024Review
- A benchmark dataset for machine learning in ecotoxicology.Scientific data · 2023Article
- Cheminformatics and artificial intelligence for accelerating agrochemical discovery.Frontiers in chemistry · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent years have seen a substantial growth in the adoption of machine learning approaches for the purposes of quantitative structure-activity relationship (QSAR) development. Such a trend has coincided with desire to see a shifting in the focus of methodology employed within chemical safety assessment: away from traditional reliance upon animal-intensive in vivo protocols, and towards increased application of in silico (or computational) predictive toxicology. With QSAR central amongst techniques applied in this area, the emergence of algorithms trained through machine learning with the objective of toxicity estimation has, quite naturally, arisen. On account of the pattern-recognition capabilities of the underlying methods, the statistical power of the ensuing models is potentially considerable-appropriate for the handling even of vast, heterogeneous datasets. However, such potency comes at a price: this manifesting as the general practical deficits observed with respect to the reproducibility, interpretability and generalisability of the resulting tools. Unsurprisingly, these elements have served to hinder broader uptake (most notably within a regulatory setting). Areas of uncertainty liable to accompany (and hence detract from applicability of) toxicological QSAR have previously been highlighted, accompanied by the forwarding of suggestions for "best practice" aimed at mitigation of their influence. However, the scope of such exercises has remained limited to "classical" QSAR-that conducted through use of linear regression and related techniques, with the adoption of comparatively few features or descriptors. Accordingly, the intention of this study has been to extend the remit of best practice guidance, so as to address concerns specific to employment of machine learning within the field. In doing so, the impact of strategies aimed at enhancing the transparency (feature importance, feature reduction), generalisability (cross-validation) and predictive power (hyperparameter optimisation) of algorithms, trained upon real toxicity data through six common learning approaches, is evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.